Surgical margins of resection for breast cancer: Current evidence

Minerva Chirurgica

Volumn 67, Issue 5, 2012, Pages 445-452

  Amato, B ^a   Rispoli, C ^b   Iannone, L ^a   Testa, S ^a   Compagna, R ^a   Rocco, N ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Department of General and Emergency Surgery   (Italy)

Author keywords

Breast neoplasms; Operative recurrence; Surgical procedures

Indexed keywords

BREAST TUMOR; FEMALE; HUMAN; PATHOLOGY; REVIEW;

BREAST NEOPLASMS; FEMALE; HUMANS;

EID: 84873548584     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Heron M. Deaths: leading causes for 2004. Natl Vital Stat Rep 2007;56:1-95.
2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92.
3. Medina-Franco H, Abarca-Pérez L, Garcia-Alvarez MN, Ulloa-Gómez JL, Romero-Trejo C, Sepulveda-Méndez J. Radioguided occult lesion localization (ROLL) versus wire-guided lumpectomy for nonpalpable breast lesions: a randomized prospective evaluation. J Surg Oncol 2008;97:108-11.
4. Singletary SE. Surgical margins in patients with earlystage breast cancer treated with breast conservation therapy. Am J Surg 2002;184:383-93.
5. Kramer S, Darsow M, Kummel S, Kimmig R, Rezai M. Breast-conserving treatment of breast cancer - oncological and reconstructive aspects. Gynakol Geburtshilfliche Rundsch 2008;48:56-62.
6. Schwartz GF, Veronesi U, Clough KB, Dixon JM, Fentiman IS, Heywang-Kòbrunner SH et al. Consensus conference on breast conservation. J Am Coll Surg 2006;203:198-207.
7. Blichert-Toft M, Nielsen M, During M, Moller S, Rank F, Overgaard M et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol 2008;47:672-81.
8. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
9. Van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000;92:1143-50.
10. Jacobs L. Positive margins: the challenge continues for breast surgeons. Ann Surg Oncol 2008;15:1271-2.
11. Kreike B, Hart AA, Van De Velde T, Borger J, Peterse H, Rutgers E et al. Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up. Int J Radiat Oncol Biol Phys 2008;71:1014-21.
12. Komoike Y, Akiyama F, Lino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S et al. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer 2006;106:35-41.
13. Nottage MK, Kopciuk KA, Tzontcheva A, Andrulis IL, Bull SB, Blackstein ME. Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study. Breast Cancer Res 2006, 8:R44.
14. Bijker N, Peterse JL, Duchateau L, Julien JP, Fentiman IS, Duval C et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263-71.
15. Mannell A. Breast-conserving therapy in breast cancer patients - a 12-year experience. S Afr J Surg 2005;43:28-30.
16. Rubio IT, Marco V. The importance of surgical margins in conservative surgery for breast cancer. Cir Esp 2006;79:3-9.
17. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
18. Yi M, Buchholz TA, Meric-Bernstam F, Bedrosian I, Hwang RF, Ross MI et al. Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg 2011;253:572-9.
19. Panet-Raymond V, Truong PT, Alexander C, Lesperance M, McDonald RE, Watson PH. Clinicopathologic factors of the recurrent tumor predict outcome in patients with ipsilateral breast tumor recurrence. Cancer 2011;117:2035-43.
20. Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol 2009;27:2466-73.
21. Smitt MC, Nowels KW, Zdeblick MJ, Jeffrey S, Carlson RW, Stockdale FE et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995;76:259-67.
22. Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999;44:1005-15.
23. Recht A, Come SE, Henderson IC, Gelman RS, Silver B, Hayes DF et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 1996;334:1356-61.
24. Pass H, Vicini FA, Kestin IX, Goldstein NS, Decker D, Pettinga J et al. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breastconserving therapy at a single institution. Cancer 2004;101:713-20.
25. Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM et al. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cancer 2005;104:20-9.
26. Lupe K, Truong PT, Alexander C, Lesperance M, Speers C, Tyldesley S. Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy. Int J Radiat Oncol Biol Phys 2011;81(4):e561-8.
27. Groot G, Rees H, Pahwa P, Kanagaratnam S, Kinloch M. Predicting local recurrence following breastconserving therapy for early stage breast cancer: the significance of a narrow (±2 mm) surgical resection margin. J Surg Oncol 2011;103:212-6.
28. Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011;103:478-88.
29. Dunne C, Burke JP, Morrow M, Kell MR. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 2009;27:1615-20.
30. MacDonald HR, Silverstein MJ, Mabry H, Mabry H, Moorthy B, Ye W, Epstein MS et al. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg 2005;190:521-5.
31. Rudloff U, Jacks LM, Goldberg JI, Wynveen CA, Brogi E, Patii S et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 2010;28:3762-9.
32. Cendan JC, Coco D, Copeland EM, III. Accuracy of intraoperative frozen-section analysis of breast cancer lumpectomy-bed margins. J Am Coll Surg 2005;201:194-8.
33. D'Halluin F, Tas P, Rouquette S, Bendavid C, Foucher F, Meshba H et al. Intraoperative touch preparation cytology following lumpectomy for breast cancer: a series of 400 procedures. Breast 2009;18:248-53.
34. Valdes EK, Boolbol SK, Cohen JM, Feldman SM. Intraoperative touch preparation cytology: does it have a role in re-excision lumpectomy? Ann Surg Oncol 2007;14:1045-50.
35. Dener C, Inan A, Sen M, Demirci S. Interoperative frozen section for margin assessment in breast conserving energy. Scand J Surg 2009;98:34-40.
36. Huston TL, Pigalarga R, Osborne MP, Tousimis E. The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery. Am J Surg 2006;192:509-12.
37. Rizzo M, Iyengar R, Gabram SG, Park J, Birdsong G, Chandler KL et al. The effects of additional tumor cavity sampling at the time of breast-conserving surgery on final margin status, volume of resection, and pathologist workload. Ann Surg Oncol 2010;17:228-34.
38. Jacobson AF, Asad J, Boolbol SK, Osborne MP, Boachie-Adjei K, Feldman SM et al. Do additional shaved margins at the time of lumpectomy eliminate the need for re-excision? Am J Surg 2008;196:556-8.
39. Pleijhuis RG, Langhout GC, Helfrich W, Themelis G, Sarantopoulos A, Crane LM et al. Near-infrared fluorescence (NIRF) imaging in breast-conserving surgery: assessing intraoperative techniques in tissue-simulating breast phantoms. Eur J Surg Oncol 2011;37:32-9.
40. Zhou C, Cohen DW, Wang Y, Lee HC, Mondelblatt AE, Tsai TH et al. Integrated optical coherence tomography and microscopy for ex vivo multiscale evaluation of human breast tissues. Cancer Res 2010;70:10071-9.
41. Singletary SE. Surgical margins in patients with earlystage breast cancer treated with breast conservation therapy. Am J Surg 2002;184:383-93.
42. Morrow M, Jagsi R, Alderman AK, Griggs JJ, Hawley ST, Hamilton AS et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 2009;302:1551-6.
43. King TA, Sakr R, Patii S, Gurevich I, Stempel M, Sampson M et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 2011;29:2158-64.
44. Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R et al. Outcome at 8 years after breastconserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000;18:1668-75.
45. Gibson GR, Lesnikoski BA, Yoo J, Mott LA, Cady B, Barth RJ Jr. A comparison of ink-directed and traditional whole-cavity re-excision for breast lumpectomy specimens with positive margins. Ann Surg Oncol 2001;8:693-704.
46. Aziz D, Rawlinson E, Narod SA, Sun P, Lickley HL, McCready DR et al. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer. Breast J 2006;12:331-7.
47. Kreike B, Hart AA, Van De Velde T, Borger J, Peterse H, Rutgers E et al. Continuing risk of ipsllateral breast relapse after breast-conserving therapy at long-term follow-up. Int J Radiat Oncol Biol Phys 2008;71:1014-21.
48. Hewes JC, Imkampe A, Haji A, Bates T. Importance of routine cavity sampling in breast conservation surgery. Br J Surg 2009;96:47-53.
49. Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P et al. Radiotherapy in breastconserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 2000;355:528-33.
50. Chagpar AB, Martin RC 2nd, Hagendoorn LJ, Chao C, McMasters KM. Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique. Am J Surg 2004;188:399-402.
51. Dillon MF, Hill AD, Quinn CM, McDermott EW, O'Higgins N. A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol 2006;13:333-9.
52. Smitt MC, Horst K. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer. Ann Surg Oncol 2007;14:1040-4.
53. Schiller DE, Le LW, Cho BC, Youngson BJ, McCready DR. Factors associated with negative margins of lumpectomy specimen: potential use in selecting patients for intraoperative radiotherapy. Ann Surg Oncol 2008;15:833-42.
54. Waljee JF, Hu ES, Newman LA, Alderman AK. Predictors of re-excision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol 2008;15:1297-303.
55. Sabel MS, Rogers K, Griffith K, Jagsi R, Kleer CG, Diehl KA et al. Residual disease after re-excision lumpectomy for close margins. J Surg Oncol 2009;99:99-103.